Quinazoline derivatives

Details for Australian Patent Application No. 2005293336 (hide)

Owner AstraZeneca AB

Inventors Jung, Frederic Henri; Ple, Patrick

Agent Davies Collison Cave

Pub. Number AU-B-2005293336

PCT Pub. Number WO2006/040520

Priority 04292417.5 12.10.04 EP

Filing date 7 October 2005

Wipo publication date 20 April 2006

Acceptance publication date 28 May 2009

International Classifications

C07D 239/88 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/040520 Priority application(s): WO2006/040520

28 May 2009 Application Accepted

  Published as AU-B-2005293336

24 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005293340-Fastening band

2005293329-Improvements in drip free valves